cancer – Medxy AI

Longitudinal Risk for Suicidal Self-Directed Violence Among Veterans With Cancer

By MedXY 05/31/2026

A national study of veterans with cancer found elevated suicide-related risk that persisted for years, especially among younger, unmarried, frail, or mentally ill patients and those with certain cancers such as central nervous system and thyroid tumors.

Cardiology news Oncology

Inflammatory and Cardiac Biomarkers Predict VTE and Bleeding Risks in Cancer Patients

By MedXY 04/22/2026

Elevated levels of inflammatory and cardiac biomarkers are linked to higher risks of venous thromboembolism and bleeding in cancer patients, according to a post hoc analysis of the AVERT trial.

Cardiology Clinical Updates Diabetes & Endocrinology news

The Changing Landscape of Mortality in Diabetes: A Shift from Cardiovascular Dominance to Cancer and Dementia

By MedXY 03/14/2026

This review analyzes multinational data showing a significant decline in cardiovascular mortality among diabetes patients, alongside a concerning rise in dementia-related deaths and the emergence of cancer as a leading cause of mortality in high-income settings.

Neurology news Oncology

Medical Cannabis as an Opioid-Sparing Strategy: Evidence from Chronic and Cancer Pain Populations

By MedXY 01/01/2026

This review synthesizes recent evidence from large-scale cohorts and synthetic control studies, demonstrating that medical cannabis participation and dispensary availability are significantly associated with reduced opioid prescriptions and lower daily dosages in adults with chronic and cancer-related pain.

Neurology news Oncology

Acupuncture for Cancer-Related Insomnia: Limited, Low-Certainty Benefits Compared with Sham or No Treatment; Inferior to CBT‑I

By MedXY 12/16/2025

A 2025 Cochrane review (5 RCTs, 402 patients, mainly women with breast cancer) finds very low- to moderate-certainty evidence that acupuncture delivers small, uncertain sleep diary benefits versus sham or inactive controls and is probably less effective than CBT‑I for insomnia in people with cancer.

Cardiology news Public Health

Reduced Arsenic in Drinking Water Tied to Large Drops in Cancer and Cardiovascular Mortality

By MedXY 11/17/2025

A prospective cohort in Bangladesh found that declines in urinary arsenic were associated with substantially lower chronic-disease mortality—including cancer and cardiovascular deaths—supporting public-health efforts to reduce arsenic exposure from drinking water.

Hematology-Oncology news Oncology

Breaking the Immortality of Cancer Cells: Israel’s Groundbreaking RNA-Targeting Drug

By MedXY 11/10/2025

Israeli scientists have developed a novel small molecule drug that targets RNA structures maintaining cancer cell immortality, providing a promising new approach to treating hard-to-cure cancers with unparalleled precision.

Gastroenterology news Oncology

What patients and clinicians want to know next: UK–Ireland research priorities for oesophageal and stomach cancers

By MedXY 11/08/2025

A UK–Ireland partnership ranked the top research uncertainties for oesophagogastric cancers; priorities emphasize personalising multimodal treatment, nutrition and quality of life, and stronger patient-centred trial design to accelerate meaningful advances.

Cardiology news Oncology

Impacts of Plant-Based Diets on Multimorbidity Risk in Cancer and Cardiometabolic Diseases Across Age Groups

By MedXY 10/20/2025

This analysis of EPIC and UK Biobank cohorts reveals that healthy plant-based diets reduce multimorbidity risk of cancer and cardiometabolic diseases, especially in middle-aged adults, underscoring diet's role in chronic disease prevention and management.

Allergy & Immunology Medical News news Oncology Specialties

Why Do Chimpanzees Rarely Get Cancer? Unveiling a Key Evolutionary Difference That Could Revolutionize Immunotherapy

By MedXY 09/14/2025

New research reveals that a protein called plasmin weakens human immune response against cancer compared to chimpanzees, offering promising strategies to enhance cancer immunotherapy.

Clinical Updates news Oncology Specialties

Bridging the Gap: Addressing Inconsistent Reporting of Venous and Arterial Thrombotic Events in Cancer Clinical Trials

By MedXY 09/08/2025

Venous and arterial thrombotic events in cancer patients are underreported in clinical trials, impairing risk assessment and prevention strategies. Uniform and comprehensive reporting is imperative to improve patient outcomes and guide therapeutic decisions.

Medical News news

The Hidden Risks of Alcohol: How Drinking Raises the Risk of 61 Diseases in Men—and Why Quitting Matters

By MedXY 08/26/2025

Emerging research reveals that any alcohol consumption increases the risk of dozens of diseases, debunking myths about moderate drinking's benefits—especially for Chinese men. Quitting alcohol triggers remarkable health improvements and reduces mortality risk.

Oncology Specialties

Extended Rivaroxaban Therapy in Cancer Patients with Low-Risk Pulmonary Embolism: 6 OR 18 Months？

By MedXY 08/26/2025

An 18-month course of rivaroxaban significantly lowers recurrent venous thromboembolism compared to 6 months in cancer patients with low-risk pulmonary embolism without a substantial increase in major bleeding risk.

Oncology Specialties

Evaluating the Adjuvant Role of Low-Dose Aspirin in Cancer-Associated Venous Thromboembolism: Efficacy, Safety, and Clinical Implications

By MedXY 08/21/2025

Low-dose aspirin added to anticoagulation for cancer-associated VTE reduces recurrence and PE-related mortality but increases bleeding risk, without improving overall survival or net clinical benefit over 6 months.

Allergy & Immunology news Oncology Specialties

Emerging Roles of Circular RNAs in Cancer and Immunotherapy: Mechanisms and Clinical Potential

By MedXY 08/21/2025

Circular RNAs (circRNAs) are pivotal regulators in cancer biology and immunotherapy, acting through mechanisms such as miRNA sponging, protein interactions, and translation. Their modulation of tumor immune microenvironment offers promising therapeutic avenues despite current technical challenges.

Clinical Updates news Oncology Specialties

Revolutionizing Cancer Therapy: Synergistic Action of Two Natural Bacteria in Complete Tumor Eradication

By MedXY 08/06/2025

A novel bacteria-based therapy using two natural strains demonstrates complete tumor clearance in immunocompromised models, offering hope for cancer patients unsuitable for current immunotherapies.

Family Medicine & Nutrition Medical News news Specialties

Pickled Delights: Delicious but Potentially Dangerous?

By MedXY 08/06/2025

Explore the beloved tradition of pickled foods, their health impacts, and safer consumption tips.

Clinical Updates news Oncology Specialties

Overcoming PD-1 Inhibitor Resistance: Six Emerging Strategies from the 2025 ASCO Annual Meeting

By MedXY 08/06/2025

PD-1 inhibitor resistance is a major hurdle in cancer immunotherapy. Six leading combination strategies—including chemotherapy, anti-angiogenic agents, radiotherapy, novel checkpoint inhibitors, microbiome modulation, and ADCs—offer new hope for overcoming resistance and improving patient outcomes.

Family Medicine & Nutrition news

Unveiling the Hidden Dangers: How Dining Habits Can Impact Your Health

By MedXY 07/26/2025

Explore how everyday dining habits can lead to health risks, including cancer, and learn preventive measures.

news Oncology Rehabilitation Medicine Specialties

The Growing Role of Music Therapy in Cancer Rehabilitation: Science, Practice, and Patient Stories

By MedXY 07/26/2025

Music therapy is emerging as a promising approach in cancer recovery, easing symptoms, supporting mental health, and enhancing quality of life. Scientific evidence and practical recommendations reveal its growing value.